Calvarium indentations in multiple myeloma and CAR T-cell therapy

被引：0
|
作者：
Munoz, Javier [1 ]
Larsen, Jeremy [1 ]
机构：
[1] Mayo Clin, Haematol & Oncol, Phoenix, AZ 85054 USA
来源：
LANCET | 2022年 / 400卷 / 10349期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [41] MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma
    Landgren, Ola
    Kazandjian, Dickran
    BLOOD CANCER DISCOVERY, 2023, 4 (05): : 346 - 348
  • [42] Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy
    Coffey, David G.
    Atilla, Pinar Ataca
    Atilla, Erden
    Landgren, Ola
    Cowan, Andrew J.
    Simon, Sylvain
    Pont, Margot J.
    Comstock, Melissa L.
    Hill, Geoffrey R.
    Riddell, Stanley R.
    Green, Damian J.
    BLOOD, 2025, 145 (02) : 220 - 233
  • [43] Anti-BCMA CAR T-cell Therapy Reins in Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (07) : 817 - 819
  • [44] Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Dima, Danai
    Ahmed, Nausheen
    DeJarnette, Shaun
    McGuirk, Joseph P.
    Khouri, Jack
    Valent, Jason
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142
  • [45] NURSING IMPLICATIONS FOR MULTIPLE MYELOMA PATIENTS UNDERGOING CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [46] Nursing implications for multiple myeloma patients undergoing chimeric antigen receptor (CAR) T-cell therapy
    Florendo, Erika
    Catamero, Donna
    Mancia, Ines Stefania
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E350 - E350
  • [47] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    Mattia D’Agostino
    Noopur Raje
    Leukemia, 2020, 34 : 21 - 34
  • [48] The activated conformation of integrin β7 as a target for multiple myeloma-specific CAR T-cell therapy
    Hosen, Naoki
    Hasegawa, Kana
    Oji, Yusuke
    Kumanogoh, Atsushi
    Sugiyama, Haruo
    CANCER SCIENCE, 2018, 109 : 837 - 837
  • [49] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    D'Agostino, Mattia
    Raje, Noopur
    LEUKEMIA, 2020, 34 (01) : 21 - 34
  • [50] Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable
    Ailawadhi, Sikander
    Shune, Leyla
    Wong, Sandy W.
    Lin, Yi
    Patel, Krina
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : e217 - e225
12345